Securities code: 300534 securities abbreviation: Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) Announcement No.: 2022-009 Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534)
Announcement of resolutions of the first extraordinary general meeting of shareholders in 2022
Special tips:
1. There is no increase, change or rejection of proposals at this shareholders’ meeting;
2. This general meeting of shareholders does not involve changing the resolution of the previous general meeting of shareholders;
3. The general meeting of shareholders was held by combining on-site voting and online voting.
1、 Meetings held
1. Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) (hereinafter referred to as “the company”) the notice of the first extraordinary general meeting of shareholders in 2022 was issued in the form of announcement on December 28, 2021. The meeting was held by combining on-site voting and online voting. The company issued the suggestive announcement on convening the first extraordinary general meeting of shareholders in 2022 on January 12, 2022. For details, see the announcement issued by the company on the information disclosure website designated by the CSRC on that day.
2. Equity registration date: Friday, January 7, 2022
3. Date and time of the meeting
(1) On site meeting time: 14:00 p.m. on Thursday, January 13, 2022.
(2) Online voting time: January 13, 2022. Among them, the specific time for online voting through the trading system of Shenzhen stock exchange is the trading time of Shenzhen Stock Exchange on the date of the first extraordinary general meeting of shareholders in 2022 (9:15-9:25 a.m. and 9:30-11:30 p.m., 13:00-15:00 p.m.); The specific time for online voting through the Internet voting system is any time from 9:15 to 15:00 on the date of the first extraordinary general meeting of shareholders in 2022.
4. On site meeting place: conference room on the sixth floor of the company, No. 10, Guoguo Road, Yuzhong County, Lanzhou City, Gansu Province
5. Meeting method: the shareholders’ meeting adopts the combination of on-site voting and online voting. 6. Convener: Board of directors
7. Moderator: Mr. Kang Haijun, chairman
8. The convening, convening procedures and voting methods of the general meeting of shareholders comply with the provisions of relevant laws, administrative regulations, departmental rules, normative documents and the articles of association.
2、 Attendance at the meeting
1. General information of shareholders attending the meeting
There are 10 shareholders and shareholder representatives participating in the on-site voting and online voting of the company’s general meeting of shareholders. The number of voting shares representing the company is 115637982, accounting for 38.1209% of the total voting shares of the company.
2. Attendance of shareholders at on-site meetings
There were 6 shareholders and shareholder representatives voting at the on-site meeting of the company’s general meeting, and the number of voting shares representing the company was 115624032, accounting for 38.1163% of the total voting shares of the company.
3. Online voting
There are 4 shareholders voting online through the trading system and Internet voting system of Shenzhen Stock Exchange, and the number of voting shares representing the company is 13950, accounting for 0.0046% of the total voting shares of the company.
4. Overall attendance of minority shareholders
There are 4 small and medium-sized investors (except directors, supervisors, senior managers and other shareholders who individually or jointly hold more than 5% of the shares of the company), representing 13950 voting shares, accounting for 0.0046% of the total voting shares of the company.
5. Other persons attending the meeting
Directors, supervisors, non directors and senior managers of the company, and witness lawyers employed by the company.
3、 Deliberation and voting of proposals
The general meeting of shareholders was voted by the combination of on-site voting and online voting. The participating shareholders and shareholder representatives considered the following proposals and formed resolutions:
1. The proposal on employing the company’s audit institution in 2021 was deliberated and adopted
Voting results: 115626232 shares were approved, accounting for 99.9898% of the shares held by all shareholders attending the meeting; 11750 opposition shares, accounting for 0.0102% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting.
Voting of minority shareholders: 2200 shares were approved, accounting for 15.7706% of the shares held by minority shareholders attending the meeting; 11750 opposed shares, accounting for 84.2294% of the shares held by minority shareholders attending the meeting; Abstained 0 shares (including 0 shares by default due to non voting), accounting for 0% of the shares held by minority shareholders attending the meeting. The motion was passed.
4、 Legal opinions issued by lawyers
Lawyer Li zongfeng and lawyer Du Xinyi of Beijing Deheng (Lanzhou) law firm attended the shareholders’ meeting, witnessed the meeting and issued a legal opinion. They believed that Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) the convening and convening procedures of the shareholders’ meeting, the qualifications of participants, the qualifications of conveners, proposals and voting procedures were in line with the company law, the articles of association and other laws According to the provisions of laws, regulations and normative documents, the resolutions adopted at the general meeting of shareholders are legal and effective.
5、 Documents for future reference
1. Resolution of the first extraordinary general meeting of shareholders in Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) 2022. 2. Legal opinion of Beijing Deheng (Lanzhou) law firm on Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) the first extraordinary general meeting of shareholders in 2022.
It is hereby announced.
Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) board of directors January 13, 2022
